My Dividend Cut Letter Arrived on a Friday the 13th and Paid $0.10 a Share

Friday, February 13, 2026, 4:52 PM. The envelope sat in our mailbox between a grocery circular and a dental reminder, corporate letterhead from the regional utility I'd held for nine years, first line announcing a board decision to rebase the quarterly distribution from $0.66 to $0.41 per share effective April. Thirty-eight percent gone while my dinner got cold on the counter. Approximately 1,150 shares meant the cut cost about $1,145 per year of anticipated income — real money against a car payment, trivial beside the psychological invoice. For nearly a decade this position anchored my "income sleeve," selected originally because marketing materials across three different sources called it a safe compounder with sixty consecutive years of increases somewhere up its family tree. The kicker unwraps midway: the same letter included a buyback authorization and an executive paragraph praising balance sheet strength that arrived one full quarter AFTER insiders had quietly trimmed their personal stakes, visible all along inside SEC Form 4 filings anyone could pull free from EDGAR within ninety seconds.

how yield seduced a skeptic

Backstory matters because I resisted dividend cultism initially. A Vanguard target-date fund carried retirement duties since 2011 while extra savings tested things — crypto once painfully during the 2018 unwind, modest caps briefly, then the utility around March 2017 when a colleague swore income stocks smoothed volatility better than anything else he'd owned across decades. Yield on offer then: 4.3 percent. Compare high-yield savings accounts scraping barely above one percent that spring and the pitch marketed itself. Nine years of reinvested distributions compounded the stake from $40,000 initial toward 1,150 shares plus accumulated dollars elsewhere in supposedly defensive names: two REITs, one pipeline operator, each chosen thru identical shorthand — yield percentage plus brand nostalgia plus somebody's newsletter saying "fortress."

the quarter of whimpers beforehand

Signals existed tho sympathy blinds. Q3 2025 earnings showed free cash flow coverage slipping under 1.1x versus historical 1.5x neighborhood, disclosed plainly across tables journalists summarized kindly as "transitional." Debt maturities stacked awkwardly thru 2027 refinancing at materially higher coupons given post-2022 rate reality. Form 4 filings recorded insider disposals worth approximately $210,000 combined during December alone among named officers, timestamped publicly for eternity. Later forensic reconstruction using nothin beyond EDGAR plus spare evenings reconstructed warning sequence any patient auditor catches routinely: coverage deterioration preceded insider sales which preceded guidance withdrawal which preceded my Friday envelope by precisely five months elapsed.

sell half or sell everything debate

Post-letter weekend hashed out options honestly alongside my wife Sunday over leftovers. Total exit grasped whatever remained near $29 share price — down 24 percent from my blended basis near $38 after years reinvesting dividends upward into climbing prices during rate hikes eroding utilities broadly. Chose partial discipline ultimately: sold two-thirds February 18-20 across three sessions netting proceeds toward broad index fund rebalancing while retaining 380 shares whose reduced payout still contributes modestly monthly. Tax mathematics complicated everything appropriately since nine years' basis carried mostly long-term gains treatment anyways due patient holding rather than active churning penalties short timelines would trigger otherwise.

reinvested tears count double

Aggregate accounting stings honestly tallied: cumulative dividends received historically approximated $21,800 while paper depreciation since inception totals similar magnitude netting lifetime experience approximately breakeven pretax before inflation adjustments — meaning nine years produced approximately zero real return versus index alternative gaining multiples meanwhile unbothered. That comparison hurts worst studied directly side-by-side spreadsheet January mornin: identical $40,000 placed instead within plain S&P 500 fund concurrently valued beyond $95,000 including dividends nobody ever slashed there historically through comparable windows encompassing pandemic crash plus hiking cycle fully absorbed silently.

the reinvestment setting I never touched

One mechanical contributor deserves naming cuz thousands own it silently: my dividend reinvestment plan had auto-bought additional shares every quarter for nine years, including three purchases during 2025's deteriorating quarters at prices above where February's letter eventually marked reality. Reinvesting into a weakening payout story compounds the wrong asset eagerly. Disabling DRIP across every income position took nine minutes total that February weekend, done before any selling decision, reversing a default installed March 2017 during initial purchase and reviewed exactly zero times since. Defaults outlive convictions; write yours down somewhere checkable.

aunt's envelopes versus my letters

Family history runs deep regarding payouts formally. Aunt Ruthie collected telecom dividends physically across Newark decades, endorsing checks monthly like guestbook entries til her building super knew her schedule intimately around mail timing rhythms. Her method wasn't sophistication either — just scale modest enough where cuts bruised pride not security. Mine scaled large enough requiring honest math upon rupture rather than folklore defense mechanisms communities construct collectively whenever shared narratives fracture visibly online forums brigade authorship afterward.

mailbox vigilance going forward

February 13ths now carry ritual weight permanently installed: annual portfolio audit re-verifying payout coverage ratios manually against latest filings every second weekend each February regardless market conditions anywhere globally. Original letter lives archived beside that same dental reminder, intact — two unsolicited health warnings arriving in one mailbox targeting different anatomies entirely. Coverage below 1.2x now triggers automatic position review, a threshold written into page 47 of my paper planner last March and treated as non-negotiable since. Yield remains welcome at my table; durability gets verified first now, forever, the way meteorologists check radar before promising anyone a dry picnic.